These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates appetite and digestion. The medications control blood sugar and help people eat less,

Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left more money in people’s wallets. Lighter passengers are saving airlines 100 million litres of fuel each year. And billions of people are enjoying a better quality of life, with improvements to their mental and physical health.

Novo Nordisk (NVO), the maker of blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, has entered an agreement with Denmark-based Ascendis Pharma (ASND) to leverage the latter’s advanced drug delivery technology.

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a red-hot market hinges on it.

The increasing use of Ozempic for modest weight loss has sparked intense debate within medical communities, raising questions about effectiveness, safety, and

Lizzo’s Halloween costume was the perfect response to her May ‘South Park’ feature and recent allegations that she took Ozempic to lose weight.

Hims & Hers and other telehealth providers say employers that balked at pricey brand-name shots are investigating cheaper off-brand alternatives.